Nanjing Vishee Medical Technology Co., Ltd (SHSE:688580) agreed to acquire a 70% stake in Hefei Hans Curestar Laser Device Co., Ltd. from Wang Bizhan, Huang Heng, Yang Aichun and Xu Qingfen for CNY 58.8 million on October 31, 2022. Nanjing Vishee Medical Technology will pay consideration from own funds. For the period September 30, 2022, Hefei Hans had CNY 17.61 million of net assets and CNY 22.80 million total assets.
Nanjing Vishee Medical Technology Co., Ltd
Equities
688580
CNE1000041Q0
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.19 CNY | -1.53% | +4.27% | -29.31% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.31% | 424M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- 688580 Stock
- News Nanjing Vishee Medical Technology Co., Ltd
- Nanjing Vishee Medical Technology Co., Ltd agreed to acquire a 70% stake in Hefei Hans Curestar Laser Device Co., Ltd. from Wang Bizhan, Huang Heng, Yang Aichun and Xu Qingfen for CNY 58.8 million.